20132066

Source:http://linkedlifedata.com/resource/pubmed/id/20132066

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0019982, umls-concept:C0025677, umls-concept:C0030705, umls-concept:C0040223, umls-concept:C0087111
pubmed:issue	1
pubmed:dateCreated	2010-2-5
pubmed:abstractText	To describe time to methotrexate (MTX) treatment among patients with a first-time diagnosis of rheumatoid arthritis (RA) in a hospital-based department of rheumatology.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0321213
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
pubmed:status	MEDLINE
pubmed:issn	1502-7732
pubmed:author	pubmed-author:JohansenMM, pubmed-author:NørgaardMM, pubmed-author:Stengaard-PedersenKK, pubmed-author:de ThurahAA
pubmed:issnType	Electronic
pubmed:volume	39
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	19-25
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20132066-Adolescent, pubmed-meshheading:20132066-Adult, pubmed-meshheading:20132066-Age Factors, pubmed-meshheading:20132066-Aged, pubmed-meshheading:20132066-Aged, 80 and over, pubmed-meshheading:20132066-Antirheumatic Agents, pubmed-meshheading:20132066-Arthritis, Rheumatoid, pubmed-meshheading:20132066-C-Reactive Protein, pubmed-meshheading:20132066-Cohort Studies, pubmed-meshheading:20132066-Confidence Intervals, pubmed-meshheading:20132066-Denmark, pubmed-meshheading:20132066-Dose-Response Relationship, Drug, pubmed-meshheading:20132066-Drug Administration Schedule, pubmed-meshheading:20132066-Female, pubmed-meshheading:20132066-Follow-Up Studies, pubmed-meshheading:20132066-Humans, pubmed-meshheading:20132066-Inflammation Mediators, pubmed-meshheading:20132066-Kaplan-Meier Estimate, pubmed-meshheading:20132066-Male, pubmed-meshheading:20132066-Methotrexate, pubmed-meshheading:20132066-Middle Aged, pubmed-meshheading:20132066-Odds Ratio, pubmed-meshheading:20132066-Outpatient Clinics, Hospital, pubmed-meshheading:20132066-Probability, pubmed-meshheading:20132066-Proportional Hazards Models, pubmed-meshheading:20132066-Referral and Consultation, pubmed-meshheading:20132066-Retrospective Studies, pubmed-meshheading:20132066-Rheumatology, pubmed-meshheading:20132066-Risk Assessment, pubmed-meshheading:20132066-Severity of Illness Index, pubmed-meshheading:20132066-Sex Factors, pubmed-meshheading:20132066-Treatment Outcome, pubmed-meshheading:20132066-Young Adult
pubmed:year	2010
pubmed:articleTitle	Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
pubmed:affiliation	Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark. annethur@rm.dk
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't